2 reports

  • ITALY: CANCER BIOMARKERS MARKET, BY CANCER TYPE, 2015-2022 (USD MILLION)

Around ##% of Italian biotechnology companies are active in the sectors of genomics, proteomics, and enabling technologies.

  • Cancer
  • Genomics Proteomics And Enabling Technology
  • North America
  • Market Size
  • Roche Group

AROUND ##% OF THE BIOTECHNOLOGY COMPANIES IN ITALY ARE ACTIVE IN THE SECTORS OF GENOMICS, PROTEOMICS, AND ENABLING TECHNOLOGIES (GPET).

  • Genomics Proteomics And Enabling Technology
  • Proteomics
  • North America
  • Forecast
  • Thermo Fisher Scientific, Inc.